Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution.
Hematol Rep
; 14(2): 135-142, 2022 Apr 13.
Article
de En
| MEDLINE
| ID: mdl-35466184
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Langue:
En
Journal:
Hematol Rep
Année:
2022
Type de document:
Article
Pays d'affiliation:
Italie
Pays de publication:
Suisse